跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,230 条关于
“Clostridioides difficile colitis”
全部
4,230
临床试验
3,520
药物
69
机构
4
资讯
637
11个月前
Large-Scale Pharmacovigilance Study Reveals Distinct Infection Risk Profiles Among Immune Checkpoint Inhibitors
去年
Advances in Clostridioides difficile Research: Rebyota's Continued Efficacy and Vancomycin's Impact
去年
Advancements in Clostridioides difficile Treatment and Prevention Highlighted in 2024
去年
VE303 Shows Promise in Preventing Recurrent Clostridioides difficile Infection
去年
Ibezapolstat Shows Promise in Phase 2 Trial for Clostridioides difficile Infection
去年
Vedanta Biosciences' VE202 Fails Phase 2 Trial for Ulcerative Colitis, Company Refocuses on C. difficile Program
2个月前
Immuron Engages Pullan Consulting to Secure Partner for IMM-529, a Novel Oral Polyclonal Antibody for Clostridioides difficile Infection
去年
REBYOTA Shows Sustained Efficacy in Preventing C. difficile Infection Recurrence
去年
FDA-Approved Vowst Offers Novel Treatment Approach for Recurrent C. difficile Infections
3个月前
RNA-Based Molecular Test More Accurately Distinguishes Active C. difficile Infection from Colonization
第 1 页，共 64 页
上一页
下一页
